908 Devices Inc. (MASS) Key Metrics
MASS valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $465.4M
- Enterprise value
- $355.4M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 7.6 10-yr median 5.1
- Price / book
- 3.6 10-yr median 1.4
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.62
MASS key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsMASS valuation Price multiples at each fiscal year-end price.
MASS returns How much profit the business earns on the capital it uses.
MASS per-share figures Results divided by the shares outstanding at year-end.
MASS financial health Debt, liquidity and how easily interest is covered.
MASS efficiency & capital use Working capital cycle and where the cash goes.
MASS valuation history
MASS returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
MASS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
MASS cash returned to shareholders
MASS price vs earnings per share
MASS key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $204.3M | $75.0M | $361.7M | $240.0M | $723.3M | — | — | — |
| Enterprise value | $108.1M | $12.0M | $222.0M | $71.1M | $520.0M | — | — | — |
| Price / sales | 3.6 | 1.3 | 7.2 | 5.1 | 17.1 | — | — | — |
| Price / book | 1.4 | 0.7 | 2.2 | 1.3 | 3.4 | — | — | — |
| EV / sales | 1.9 | 0.2 | 4.4 | 1.5 | 12.3 | — | — | — |
| Earnings yield | −17.9% | −96.3% | −10.1% | −13.2% | −3.1% | — | — | — |
| Free cash flow yield | −12.1% | −41.1% | −7.5% | −9.6% | −4.1% | — | — | — |
| Dividend yield | — | — | — | 0.1% | — | — | — | — |
| Shareholder yield (dividends + buybacks) | — | — | 0.2% | 0.2% | 0.0% | — | — | — |
| Share price at fiscal year-end | $5.25 | $2.20 | $11.22 | $7.62 | $25.87 | $56.95 | — | — |
| Per share | ||||||||
| Revenue per share | $1.44 | $1.75 | $1.56 | $1.49 | $1.51 | — | — | — |
| Earnings per share | −$0.94 | −$2.12 | −$1.13 | −$1.01 | −$0.79 | — | — | — |
| Operating cash flow per share | −$0.61 | −$0.89 | −$0.78 | −$0.66 | −$1.04 | — | — | — |
| Free cash flow per share | −$0.63 | −$0.91 | −$0.84 | −$0.73 | −$1.07 | — | — | — |
| Cash per share | $2.90 | $2.04 | $4.52 | $5.98 | $8.01 | — | — | — |
| Book value per share | $3.69 | $3.36 | $5.13 | $6.05 | $7.68 | — | — | — |
| Tangible book value per share | $2.76 | $2.03 | $4.57 | $5.46 | $7.68 | — | — | — |
| Dividends per share | — | — | — | $0.01 | — | — | — | — |
| Capex per share | $0.02 | $0.02 | $0.06 | $0.06 | $0.03 | — | — | — |
| Debt per share | $0.43 | $0.19 | $0.18 | $0.62 | $0.75 | — | — | — |
| Shares outstanding | 38.9M | 34.1M | 32.2M | 31.5M | 28.0M | — | — | — |
| Change in shares outstanding | +14.2% | +5.7% | +2.4% | +12.6% | — | — | — | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | −28.4% | −51.6% | −20.4% | −15.7% | −12.5% | −33.8% | — | — |
| Return on invested capital (ROIC) | −38.6% | −156.7% | −142.4% | −169.1% | −267.1% | — | — | — |
| Return on assets (ROA) | −21.0% | −39.8% | −16.3% | −12.6% | −10.1% | −11.8% | −40.9% | −27.2% |
| Return on tangible assets | −23.8% | −63.2% | −19.7% | −14.2% | −8.5% | −7.2% | −35.5% | −27.2% |
| Free cash flow margin | −43.9% | −51.7% | −54.0% | −49.0% | −70.7% | 15.3% | −63.4% | −43.6% |
| Financial health | ||||||||
| Total debt | $16.7M | $6.6M | $5.9M | $19.5M | $20.9M | $21.9M | $22.8M | $17.9M |
| Cash & short-term investments | $113.0M | $69.6M | $145.7M | $188.4M | $224.1M | $159.2M | $17.9M | $7.1M |
| Net debt | −$96.3M | −$63.0M | −$139.7M | −$168.9M | −$203.2M | −$137.4M | $4.9M | $10.9M |
| Debt / equity | 0.12 | 0.06 | 0.04 | 0.10 | 0.10 | 0.16 | — | — |
| Debt / assets | 0.09 | 0.04 | 0.03 | 0.08 | 0.08 | 0.12 | 0.61 | 0.65 |
| Current ratio | 4.24 | 4.10 | 7.71 | 11.22 | 17.05 | 15.78 | 4.72 | 3.61 |
| Quick ratio | 3.86 | 3.45 | 7.04 | 10.56 | 16.51 | 15.36 | 3.86 | 2.87 |
| Interest coverage | — | — | -212.7 | -274.3 | -45.4 | -6.0 | -7.9 | -5.6 |
| Working capital | $110.5M | $77.9M | $151.2M | $196.4M | $238.1M | $160.1M | $22.5M | $12.4M |
| Invested capital | $47.4M | $51.6M | $25.8M | $21.7M | $11.4M | $1.7M | −$58.3M | −$39.3M |
| Tangible asset value | $107.3M | $69.3M | $147.3M | $172.1M | $214.6M | $139.0M | −$63.2M | −$50.2M |
| Net current asset value | $98.2M | $58.2M | $136.3M | $163.6M | $206.6M | $131.2M | −$72.2M | −$60.7M |
| Graham net-net per share | $2.10 | $1.24 | $3.80 | $4.77 | $6.94 | — | — | — |
| Capital allocation | ||||||||
| Dividends paid | — | — | — | $262,000 | — | — | — | — |
| Share buybacks (net) | — | — | $776,000 | $262,000 | $0 | — | — | — |
| Capex / revenue | 1.7% | 1.0% | 4.1% | 4.4% | 1.7% | 0.0% | 2.2% | 3.3% |
| Capex / operating cash flow | — | — | — | — | — | 0.2% | — | — |
| Capex / depreciation | 0.21 | 0.13 | 0.86 | 1.27 | 0.80 | 0.01 | 0.44 | 0.81 |
| Stock-based compensation / revenue | 17.5% | 19.7% | 19.5% | 15.4% | 5.9% | 2.0% | 1.5% | 1.0% |
| R&D / revenue | 24.6% | 42.8% | 43.6% | 37.4% | 31.0% | 30.6% | 50.0% | 43.2% |
| SG&A / revenue | 68.6% | 89.9% | 92.0% | 93.7% | 76.4% | 46.5% | 62.8% | 42.2% |
| Efficiency | ||||||||
| Days sales outstanding | 77.8 | 66.2 | 69.1 | 103.6 | 101.2 | 80.8 | 115.9 | 104.9 |
| Days of inventory on hand | 181.0 | 191.1 | 201.1 | 179.0 | 120.1 | 149.5 | 162.7 | 133.1 |
| Days payables outstanding | 65.1 | 20.0 | 19.0 | 24.3 | 22.8 | 24.1 | 22.7 | 24.4 |
| Cash conversion cycle (days) | 193.7 | 237.3 | 251.3 | 258.4 | 198.4 | 206.2 | 255.9 | 213.6 |
| Receivables turnover | 4.69 | 5.52 | 5.28 | 3.52 | 3.61 | 4.52 | 3.15 | 3.48 |
| Payables turnover | 5.61 | 18.26 | 19.25 | 15.05 | 15.98 | 15.14 | 16.09 | 14.98 |
| Inventory turnover | 2.02 | 1.91 | 1.81 | 2.04 | 3.04 | 2.44 | 2.24 | 2.74 |
| Asset turnover | 0.32 | 0.33 | 0.23 | 0.19 | 0.19 | 0.25 | 0.55 | 0.79 |
| Average receivables | $12.0M | $10.8M | $9.5M | $13.3M | $11.7M | $6.0M | $5.7M | $6.3M |
| Average payables | $5.2M | $1.6M | $1.3M | $1.4M | $1.2M | $790,500 | $611,000 | $645,000 |
| Average inventory | $14.6M | $15.6M | $13.7M | $10.2M | $6.2M | $4.9M | $4.4M | $3.5M |
| Intangibles / total assets | 19.2% | 28.4% | 9.0% | 7.6% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from MASS's annual financial statements (latest annual report filed March 9, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
MASS valuation and financial ratios
908 Devices earned a return on equity of −28.4% and a return on invested capital of −38.6% in fiscal 2025. It ended the year with $16.7 million of debt and $113.0 million in cash and short-term investments, a net cash position of $96.3 million.
See the MASS income statement, the MASS chart for price history, or the MASS stock overview for the latest quote and news.
MASS key metrics FAQ
What is 908 Devices's return on equity?
908 Devices's return on equity (ROE) was −28.4% in fiscal 2025: net income of -$36.6 million on average shareholders' equity of $129.1 million.
What is 908 Devices's ROIC?
908 Devices's return on invested capital was −38.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does 908 Devices have?
908 Devices had total debt of $16.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.12 and more cash than debt.
What is 908 Devices's free cash flow yield?
908 Devices generated -$24.6 million of free cash flow in fiscal 2025, a free cash flow yield of −12.1% on its market value at year-end ($204.3 million).
What is 908 Devices's current ratio?
908 Devices's current ratio was 4.24 at the end of fiscal 2025: current assets were 4.24 times current liabilities.